280 related articles for article (PubMed ID: 17910626)
1. Platelet glycoprotein VI-related clinical defects.
Arthur JF; Dunkley S; Andrews RK
Br J Haematol; 2007 Nov; 139(3):363-72. PubMed ID: 17910626
[TBL] [Abstract][Full Text] [Related]
2. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
3. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein VI: its structure and function.
Moroi M; Jung SM
Thromb Res; 2004; 114(4):221-33. PubMed ID: 15381385
[TBL] [Abstract][Full Text] [Related]
5. Measuring soluble platelet glycoprotein VI in human plasma by ELISA.
Al-Tamimi M; Mu FT; Moroi M; Gardiner EE; Berndt MC; Andrews RK
Platelets; 2009 May; 20(3):143-9. PubMed ID: 19437330
[TBL] [Abstract][Full Text] [Related]
6. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
7. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus.
Takahashi H; Moroi M
Am J Hematol; 2001 Aug; 67(4):262-7. PubMed ID: 11443641
[TBL] [Abstract][Full Text] [Related]
8. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion.
Jung SM; Takemura Y; Imamura Y; Hayashi T; Adachi E; Moroi M
Platelets; 2008 Feb; 19(1):32-42. PubMed ID: 18231936
[TBL] [Abstract][Full Text] [Related]
9. Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.
Boylan B; Chen H; Rathore V; Paddock C; Salacz M; Friedman KD; Curtis BR; Stapleton M; Newman DK; Kahn ML; Newman PJ
Blood; 2004 Sep; 104(5):1350-5. PubMed ID: 15150079
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI.
Ezumi Y; Uchiyama T; Takayama H
Biochem Biophys Res Commun; 2000 Oct; 277(1):27-36. PubMed ID: 11027634
[TBL] [Abstract][Full Text] [Related]
11. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo.
Schulz C; Penz S; Hoffmann C; Langer H; Gillitzer A; Schneider S; Brandl R; Seidl S; Massberg S; Pichler B; Kremmer E; Stellos K; Schönberger T; Siess W; Gawaz M
Basic Res Cardiol; 2008 Jul; 103(4):356-67. PubMed ID: 18431526
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI.
Ono K; Ueda H; Yoshizawa Y; Akazawa D; Tanimura R; Shimada I; Takahashi H
J Med Chem; 2010 Mar; 53(5):2087-93. PubMed ID: 20158191
[TBL] [Abstract][Full Text] [Related]
13. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
[TBL] [Abstract][Full Text] [Related]
14. Platelet glycoprotein VI.
Jung SM; Moroi M
Adv Exp Med Biol; 2008; 640():53-63. PubMed ID: 19065783
[TBL] [Abstract][Full Text] [Related]
15. Regulation of platelet glycoprotein VI (GPVI) surface expression and of soluble GPVI in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS).
Bigalke B; Stellos K; Weig HJ; Geisler T; Seizer P; Kremmer E; Pötz O; Joos T; May AE; Lindemann S; Gawaz M
Basic Res Cardiol; 2009 May; 104(3):352-7. PubMed ID: 19190951
[TBL] [Abstract][Full Text] [Related]
16. Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome.
Nurden P; Jandrot-Perrus M; Combrié R; Winckler J; Arocas V; Lecut C; Pasquet JM; Kunicki TJ; Nurden AT
Blood; 2004 Jul; 104(1):107-14. PubMed ID: 15010364
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.
Nurden AT
Blood Rev; 2019 Nov; 38():100592. PubMed ID: 31351674
[TBL] [Abstract][Full Text] [Related]
18. GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism.
Lockyer S; Okuyama K; Begum S; Le S; Sun B; Watanabe T; Matsumoto Y; Yoshitake M; Kambayashi J; Tandon NN
Thromb Res; 2006; 118(3):371-80. PubMed ID: 16139873
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Fc receptors identify ligand binding regions in human glycoprotein VI.
Dumont B; Minullina I; Loyau S; Monteiro RC; Lacapere JJ; Arocas V; Jandrot-Perrus M
J Mol Biol; 2006 Sep; 361(5):877-87. PubMed ID: 16876821
[TBL] [Abstract][Full Text] [Related]
20. Proteolysis of platelet receptors in humans and other species.
Qiao JL; Shen Y; Gardiner EE; Andrews RK
Biol Chem; 2010 Aug; 391(8):893-900. PubMed ID: 20482312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
